A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
Joseph
J
Ciccolini
Alexandre
A
Evrard
Bruno
B
Lacarelle
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003564:Cytidine Deaminase / Q000235:genetics*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D005533:Foot Dermatoses / Q000139:chemically induced*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011355:Prodrugs / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D003564:Cytidine Deaminase; D005472:Fluorouracil